We use cookies to analyze site usage and improve your experience. Learn more

    PeptideIQPeptideIQ
    Back
    Comparison Tool

    Peptide Comparison

    Compare up to 4 peptides side by side.

    Quick Compare

    Semaglutide
    Tirzepatide
    Property
    Semaglutide
    Tirzepatide
    Half-Life~7 days~5 days
    MechanismGLP-1 receptor agonistDual GLP-1/GIP receptor agonist
    Typical Dose0.25-2.4mg weekly2.5-15mg weekly
    FrequencyOnce weeklyOnce weekly
    Administration
    Subcutaneous
    Subcutaneous
    Onset Time2-4 weeks for appetite reduction2-4 weeks for appetite reduction
    StorageRefrigerated (2-8°C)Refrigerated (2-8°C)
    Stability28 days refrigerated28 days refrigerated
    Common Uses
    Weight management
    Type 2 diabetes
    Appetite control
    Weight management
    Type 2 diabetes
    Metabolic health
    Side Effects
    Nausea
    Vomiting
    Diarrhea
    Constipation
    Nausea
    Diarrhea
    Decreased appetite
    Vomiting

    Property Comparison

    Duration
    Quick Onset
    Versatility
    Tolerability
    Use Cases
    Stackability
    DurationQuick OnsetVersatilityTolerabilityUse CasesStackability03610
    • Semaglutide
    • Tirzepatide

    Scores are derived from peptide properties. Higher = better for that attribute.

    Typical Dose Ranges

    0400080001200016000SemaglutideTirzepatide0.25-2.4mgweekly2.5-15mg weekly